Memorial Sloan-Kettering Team Confirms Link Between BRCA2 Mutation and Prostate Cancer | GenomeWeb

BRCA2 mutations appear to play a significant role in prostate cancer.

Men who inherit the genetic mutation are five times more likely to develop the cancer than non-carrying men, according to a new study conducted at Memorial Sloan-Kettering Cancer Center.

The risk, which researchers called “significantly elevated,” may encourage physicians to prescribe existing BRCA1/2 tests to some men.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.